<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Relmada Therapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Relmada Therapeutics, Inc.

    We are a clinical stage, publicly traded specialty pharmaceutical company, focused on developing dextromethadone (REL-1017) as a rapid-acting oral treatment for depression, CNS and ophthalmological disorders. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Sergio Traversa, PharmD, MBA
    • FOUNDED
      2004
    • EMPLOYEES
      0-10
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Soligenix, Inc.

    Soligenix, Inc.

    Soligenix, Inc. is a late-stage biopharmaceutical company focused on developing an...

    Soligenix, Inc. is a late-stage biopharmaceutic...

    Filing Type:    PU
    The Pennant Group, Inc.

    The Pennant Group, Inc.

    The Pennant Group, Inc. is a holding company of independent operating subsidiaries...

    The Pennant Group, Inc. is a holding company of...

    Filing Type:    PU
    Sabra Health Care REIT, Inc.

    Sabra Health Care REIT, Inc.

    As of June 30, 2019, Sabra’s investment portfolio included 432 real estate prope...

    As of June 30, 2019, Sabra’s investment portf...

    Filing Type:    PU
    Albireo Pharma, Inc.

    Albireo Pharma, Inc.

    Albireo is a clinical-stage biopharmaceutical company focused on the development a...

    Albireo is a clinical-stage biopharmaceutical c...

    Filing Type:    PU
    Karuna Therapeutics, Inc.

    Karuna Therapeutics, Inc.

    We are an innovative clinical-stage biopharmaceutical company primarily focused on...

    We are an innovative clinical-stage biopharmace...

    Filing Type:    PU
    BeiGene, Ltd.

    BeiGene, Ltd.

    BeiGene, Ltd. (“BeiGene”) is a commercial-stage biotechnology company focused ...

    BeiGene, Ltd. (“BeiGene”) is a commercial-s...

    Filing Type:    PU
    Sage Therapeutics, Inc.

    Sage Therapeutics, Inc.

    Sage Therapeutics is a biopharmaceutical company committed to developing novel the...

    Sage Therapeutics is a biopharmaceutical compan...

    Filing Type:    PU
    Fisher Wallace Laboratories, Inc.

    Fisher Wallace Laboratories, Inc.

    Fisher Wallace manufactures and markets wearable medical devices for the treatment...

    Fisher Wallace manufactures and markets wearabl...

    Amount Raised:    $670,653.00
    Fundraising Status:    EC
    Filing Type:    CF
    Aquestive Therapeutics, Inc.

    Aquestive Therapeutics, Inc.

    Aquestive Therapeutics is a specialty pharmaceutical company that advances and com...

    Aquestive Therapeutics is a specialty pharmaceu...

    Filing Type:    PU
    Trevena, Inc.

    Trevena, Inc.

    Trevena is a biopharmaceutical company focused on the development and commercializ...

    Trevena is a biopharmaceutical company focused ...

    Filing Type:    PU
    ACADIA Pharmaceuticals

    ACADIA Pharmaceuticals

    At ACADIA (NASDAQ: ACAD), we share a passion for improving the lives of patients w...

    At ACADIA (NASDAQ: ACAD), we share a passion fo...

    Filing Type:    PU
    ©2025 National Investor Network. All Rights Reserved.